CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone

BACKGROUND. Patients with glioblastoma (GBM) have an overall median survival of 15 months despite multimodal therapy. These catastrophic survival rates are to be correlated to systematic relapses that might arise from remaining glioblastoma stem cells (GSCs) left behind after surgery. In this line,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Goffart, Nicolas, Lombard, Arnaud, Lallemand, François, Kroonen, Jérôme, Nassen, Jessica, Di Valentin, Emmanuel, Berendsen, Sharon, Dedobbeleer, Matthias, Willems, Estelle, Robe, Pierre, Bours, Vincent, Martin, Didier, Martinive, Philippe, Maquet, Pierre, Rogister, Bernard
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Basic and Translational Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193023/
https://ncbi.nlm.nih.gov/pubmed/27370398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now136
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares